Trevena
TRVN
#10607
Rank
NZ$0.01 M
Marketcap
NZ$0.02078
Share price
0.00%
Change (1 day)
-99.34%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -NZ$49.98 Million

According to Trevena's latest financial reports the company's current earnings are NZ$0.54 Million. In 2023 the company made an earning of -NZ$62.9 Million, an increase over its 2022 earnings that were of -NZ$90.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$49.98 Million-20.54%
2023 -NZ$62.9 Million-30.69%
2022 -NZ$90.75 Million1.38%
2021 -NZ$89.52 Million78.04%
2020 -NZ$50.28 Million21.3%
2019 -NZ$41.45 Million-13.91%
2018 -NZ$48.15 Million-59.75%
2017 -NZ$0.12 Billion-31.77%
2016 -NZ$0.18 Billion101.73%
2015 -NZ$86.9 Million1.14%
2014 -NZ$85.93 Million114.83%
2013 -NZ$40 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.27 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.31 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.11 Billion 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.97 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.09 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.81 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA